Resultados de la búsqueda 2151-2160 of 20309 for WHO

  1. Transplant Center de Mayo Clinic - Ensayos clínicos

    ... who have an active antibody mediated rejection (AMR) after recently been kidney transplanted. The purpose is also to investigate and compare safety for ...

  2. Sarcoidosis - Atención en Mayo Clinic

    (VIDEO) 'Science of angels': A mother's thankful letter for team who diagnosed rare disease. Nancy Drourr was diagnosed with sarcoidosis in 2024 after years ...

  3. Oncología (médica) - Ensayos clínicos

    ... who have previously received 177Lu-DOTATATE for midgut neuroendocrine tumor (NET) that has spread from where it first started (primary site) to other places ...

  4. Oncología (médica) - Ensayos clínicos

    ... who have previously received 177Lu-DOTATATE for midgut neuroendocrine tumor (NET) that has spread from where it first started (primary site) to other places ...

  5. Oncología (médica) - Ensayos clínicos

    ... who have previously received 177Lu-DOTATATE for midgut neuroendocrine tumor (NET) that has spread from where it first started (primary site) to other places ...

  6. Oncología (médica) - Ensayos clínicos

    ... who have previously received 177Lu-DOTATATE for midgut neuroendocrine tumor (NET) that has spread from where it first started (primary site) to other places ...

  7. Oncología (médica) - Ensayos clínicos

    ... who have previously received 177Lu-DOTATATE for midgut neuroendocrine tumor (NET) that has spread from where it first started (primary site) to other places ...

  8. Oncología (médica) - Ensayos clínicos

    ... who have previously received 177Lu-DOTATATE for midgut neuroendocrine tumor (NET) that has spread from where it first started (primary site) to other places ...

  9. Oncología (médica) - Ensayos clínicos

    ... who have previously received 177Lu-DOTATATE for midgut neuroendocrine tumor (NET) that has spread from where it first started (primary site) to other places ...

  10. Oncología (médica) - Ensayos clínicos

    ... who have previously received 177Lu-DOTATATE for midgut neuroendocrine tumor (NET) that has spread from where it first started (primary site) to other places ...